Global shortage of two key treatments
Manx Care says there’s 'no immediate threat' to stroke patients, and those with heart conditions, due to a global shortage of two key treatments.
The Isle of Man, along with UK NHS trusts, is being asked to conserve supplies of two drugs - Alteplase and Tenecteplase - due to manufacturer issues.
The shortage is expected to last until early next year and hospitals are being asked to provide alternative treatments where appropriate.
Dr Sreeman Andole is the executive medical director, and stroke consultant, at Noble's Hospital:
Manxman sailing cancelled following late arrival into Douglas
Calls for 'transitional protections' for migrants on five-year immigration path
'No decisions have been made' over future of Ballabeg Methodist Church
Manxman's departure to Heysham delayed